NCT04237636 is a clinical trial in Acute Kidney Injury, sponsored by Xijing Hospital.

Who is sponsoring NCT04237636?

NCT04237636 is sponsored by Xijing Hospital.

What condition does NCT04237636 study?

NCT04237636 studies Acute Kidney Injury.

Is NCT04237636 still recruiting?

NCT04237636 is currently completed. Last updated 29 December 2020.

Last reviewed 2020-12-29 · How we verify

NCT04237636

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Clinical Score to Predict Acute Kidney Injury After Heart Valve Replacement Surgery

Completed Last updated 29 December 2020

What this trial tests

trial in Acute Kidney Injury in 3,392 participants. Completed in 30 June 2020.

Timeline

1 February 2020

Primary endpoint
30 June 2020

30 June 2020

Quick facts

Lead sponsor	Xijing Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	3,392
Start date	1 February 2020
Primary completion	30 June 2020
Estimated completion	30 June 2020
Sites	1 location across China

Conditions studied

Acute Kidney Injury — all drugs for Acute Kidney Injury →

Sponsor

Xijing Hospital

Who can join

Eligibility, any sex, with Acute Kidney Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute kidney injury (AKI) is a common and severe complication of cardiac surgery. The main stay treatment remains preventive with no clear evidence supporting any therapeutic interventions. AKI risk prediction scores are an objective, transparent means of cohort enrichment but are not widely used. The purpose of this analysis was to develop and validate a clinical score including pre-,intra-and post-operative predictors that predicted AKI following heart valve replacement surgery. This prediction score allows identification of patients at high risk of AKI and may support decision-making for protective kidney treatment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Perioperative parameters-based prediction model for acute kidney injury in Chinese population following valvular surgery.
Yan Y, Gong H, Hu J, Wu D, et al · · 2023 · cited 6× · PMID 36960471 · DOI 10.3389/fcvm.2023.1094997

Verify or expand the search:

Other recruiting trials for Acute Kidney Injury

Currently open trials in the same condition.

NCT07273838 — Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome · Phase 2 · recruiting
NCT07262320 — Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America · recruiting
NCT07351149 — Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery · recruiting
NCT07215702 — A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kid · Phase 2 · recruiting
NCT06654193 — Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury · Phase 1, PHASE2 · recruiting

Other Xijing Hospital trials

Trials by the same sponsor.

NCT07532096 — Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast · NA · not yet recruiting
NCT07519018 — TIS for Drug Resistant TLE · NA · not yet recruiting
NCT07518992 — Correlation Between Preoperative Sleep and Postoperative Brain and Renal Dysfunction · not yet recruiting
NCT07466303 — Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer · Phase 2 · not yet recruiting
NCT07474142 — A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve P · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04237636 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Xijing Hospital
Last refreshed: 29 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04237636.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing